Technical Analysis for DRMA - Dermata Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.38 | -2.83% | -0.10 |
DRMA closed down 2.83 percent on Friday, May 24, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -2.83% | |
| Calm After Storm | Range Contraction | -2.83% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 4 days ago |
| Possible NR7 | 4 days ago |
| Possible Inside Day | 4 days ago |
| Lower Bollinger Band Support | 4 days ago |
| Down 3% | 4 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/16/2024
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. Its lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. The company was founded in 2014 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Organ Systems Dermatology Psoriasis Acne Rosacea Skin Acne Vulgaris Cutaneous Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Organ Systems Dermatology Psoriasis Acne Rosacea Skin Acne Vulgaris Cutaneous Conditions
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.3485 |
| 52 Week Low | 3.24 |
| Average Volume | 18,741 |
| 200-Day Moving Average | 9.61 |
| 50-Day Moving Average | 5.28 |
| 20-Day Moving Average | 4.66 |
| 10-Day Moving Average | 4.27 |
| Average True Range | 0.64 |
| RSI (14) | 20.00 |
| ADX | 22.88 |
| +DI | 18.75 |
| -DI | 12.73 |
| Chandelier Exit (Long, 3 ATRs) | 4.25 |
| Chandelier Exit (Short, 3 ATRs) | 5.16 |
| Upper Bollinger Bands | 6.06 |
| Lower Bollinger Band | 3.25 |
| Percent B (%b) | 0.05 |
| BandWidth | 60.50 |
| MACD Line | -0.50 |
| MACD Signal Line | -0.34 |
| MACD Histogram | -0.1537 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.63 | ||||
| Resistance 3 (R3) | 3.66 | 3.59 | 3.59 | ||
| Resistance 2 (R2) | 3.59 | 3.53 | 3.58 | 3.58 | |
| Resistance 1 (R1) | 3.49 | 3.49 | 3.45 | 3.46 | 3.56 |
| Pivot Point | 3.42 | 3.42 | 3.41 | 3.41 | 3.42 |
| Support 1 (S1) | 3.32 | 3.36 | 3.29 | 3.30 | 3.20 |
| Support 2 (S2) | 3.25 | 3.32 | 3.24 | 3.18 | |
| Support 3 (S3) | 3.15 | 3.25 | 3.17 | ||
| Support 4 (S4) | 3.13 |
